tanshinone has been researched along with Carcinogenesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, B; Xiang, BL; Xin, G; Yuan, SF; Zhang, XL; Zhang, ZH; Zhao, JQ; Zou, F | 1 |
| Cai, F; Jiang, H; Li, Y; Ma, L; Niu, Y; Tao, Y; Wang, X; Wang, Z; Xu, X; Yu, Y; Zhang, C; Zhang, X | 1 |
| Chai, H; Ding, L; Dou, X; Hu, L; Ren, X; Tang, L; Wang, C; Xia, Y; Xie, B | 1 |
3 other study(ies) available for tanshinone and Carcinogenesis
| Article | Year |
|---|---|
Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis.
Topics: Adenocarcinoma of Lung; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Sodium | 2023 |
Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway.
Topics: Abietanes; Adaptor Proteins, Signal Transducing; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinogenesis; Cell Line, Tumor; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Female; Humans; Liver Neoplasms; Male; Middle Aged; Phytotherapy; Salvia miltiorrhiza; Smad7 Protein; Transcription Factors; Transforming Growth Factor beta; YAP-Signaling Proteins | 2019 |
Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Kinetics; Liver Neoplasms; MicroRNAs; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Signal Transduction; Transcription Factors; Tumor Suppressor Protein p53 | 2017 |